We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, E... The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified. Show more
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.17 | -2.37762237762 | 7.15 | 7.5392 | 6.86 | 122399 | 7.19750721 | SP |
| 4 | 0.56 | 8.72274143302 | 6.42 | 7.5392 | 5.76 | 90534 | 6.79753389 | SP |
| 12 | 0.7 | 11.1464968153 | 6.28 | 7.5392 | 5.76 | 77219 | 6.72363995 | SP |
| 26 | -0.73 | -9.4682230869 | 7.71 | 9.83 | 5.76 | 77894 | 7.42012023 | SP |
| 52 | -1.92 | -21.5730337079 | 8.9 | 9.97 | 4.57 | 74480 | 7.23940163 | SP |
| 156 | -17.04 | -70.9408825978 | 24.02 | 26 | 4.57 | 58180 | 11.34499922 | SP |
| 260 | -8.85 | -55.906506633 | 15.83 | 31.86 | 4.57 | 52370 | 13.48187471 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
